Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HZNP will rise by +2.07% over the next 2 Weeks and hit $118.70 by Thursday, January 30, 2025. In that time frame, HZNP's share price is expected to range between $115.97 and $121.25.
BearishAverageBullishHZNP shares remained flat 0 in Thursday, January 16, 2025's trading session, starting and closing at a previous close of $116.30 to move at $116.30. The stock demonstrated notable intraday movement (see HZNP's key stats for a full breakdown), fluctuating between $116.30 and $116.34, a +0.03% trading range. While recent weeks have seen some volatility, HZNP has managed to secure a +0.52% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 23.92M shares changing hands, 23.92M more than the previous session. This amounted to $2.78B in total market activity.
Will HZNP Continue Its Upward Trend?
According to analyst ratings and projections for HZNP, Horizon Therapeutics Public Limited Company shares are anticipated to increase by +4.94%, potentially reaching $122.34 per share by January 30, 2025. Short-term technical indicators currently suggest a neutral sentiment for HZNP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the HZNP stock forecast, now is a good time to buy HZNP stock because its current trading price is -1.86% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on HZNP covering social and institutional perspectives.
HZNP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HZNP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 80.29% to 86.58%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 66.18%, suggests strong medium-term momentum. However, the 100-day RSI, at 58.79%, maintains a neutral outlook for the long term. Insights into HZNP's shareholder base show how institutional investors are positioning themselves during these momentum shifts